Perlmutter, B. C. http://orcid.org/0000-0002-6546-3909
Alkhatib, H.
Lightner, A. L.
Fafaj, A.
Zolin, S. J.
Petro, C. C.
Krpata, D. M.
Prabhu, A. S.
Holubar, S. D.
Rosen, M. J.
Article History
Received: 5 January 2021
Accepted: 16 July 2021
First Online: 3 August 2021
Declarations
:
: Stefan Holubar has had a financial relationship with the following companies: Takeda Pharmaceutical Company, Shionogi Inc.<b>Twitter handles:</b> @BPerlmutter MD, @AlkhatibHemasat, @AmyLightnerMD, @samzolin, @ClaytonCharles, @DKrpataMD, @ajitaprabhumd, @HolubarStefan, @MikeRosenMD.
: The Institutional Review Board (IRB) of Cleveland Clinic Foundation approved all protocols and research related to this study. Due to the retrospective and low-risk nature of this study, the IRB waived the requirement to obtain informed consent from patients included in this study.
: Data will not be shared.<b>Code Availability:</b> Not applicable.